anemia in chronic kidney disease 16/jittama... · • heme iron compound : hb, myoglobin ... no...
Post on 13-Jul-2020
18 Views
Preview:
TRANSCRIPT
Iron metabolism
And
Anemia in chronic kidney disease
Chittima Sirijerachai
Iron distributionIron distribution
– Intracellular ferrous iron• Heme iron compound : Hb, myoglobin
• Iron containing enzyme
– Intracellular ferric iron• RE cell, heart, epithelial cell of small intestine
- Ferric-transferrin
Intracellular iron
Extracellular iron
Dietary iron1-2 mg/day
Liver1000 mg
Spleen600 mg
Plasma transferrin3 mg
Slough mucosal cell1-2 mg/day
Myoglobin300 mg
utilization
Bone marrow300 mg
Erythrocyte1800 mg
utilization
Iron absorptionIron absorption
Fe+++
Fe++
Fe++
Fe++ ferritin
Fe+++ - transferrin
Promote absorption
-Fructose
-Vitamin C
-Heme iron
-Amino acidInhibit absorption
-Phosphate
-Phytate
-Tannin
-Soil clay
HCl
Iron absorptionIron absorption
Regulation of iron absorptionRegulation of iron absorption
Dietary iron – mucosal block
Iron stores – store regulator
Erythropoitic regulator
Heme
Iron utilizationIron utilization
Dietary iron1-2 mg/day
Liver1000 mg
Spleen600 mg
Plasma transferrin3 mg
Slough mucosal cell1-2 mg/day
Myoglobin300 mg
utilization
Bone marrow300 mg
Erythrocyte1800 mg
utilizationIron deficiency anemiaIron deficiency anemia
PlasmaFe-Tf
Liver spleen
Bone marrow
rbc
inflammation
hepcidin
hepcidin
Anemia of chronic diseaseAnemia of chronic disease
Iron studyIron study
Serum iron
Total iron binding capacity (TIBC)
Transferrin saturation (Tf sat)
Ferritin
Iron depletionIron depletion
erythrocyte
Iron stores
normal functional absolute
Serum ferritin(ng/ml)
> 100 > 100 < 100
Tf sat%
> 20 < 20 < 20
- iron- protein- etc
erythropoietin
Decreased production
Blood lossIncreased destruction
Causes of anemia in ESRDCauses of anemia in ESRD
Decrease erythropoietinIron deficiencyNutritional deficiencyDecrease red cell survivalBone marrow suppression by uremiaOsteitis fibrosa cysticaInflammationAluminum toxicity
Work-up for a diagnosis of anemia in CKD
Work-up for a diagnosis of anemia in CKD
Adult male < 13.5 g/dl
Adult female <12.5 g/dl
Hb
Diagnosis of renal anemiaDiagnosis of renal anemia
Significant impairment of renal function
No other causes of anemia
Iron deficiency anemia
Nutritional deficiency anemia
GFR < 30 cc/min, Cr > 2 mg/dl
Diagnosis of renal anemiaDiagnosis of renal anemia
History taking
Physical examination
- Dietary intake
- Chronic blood loss
InvestigationInvestigation
CBC
Iron study, ferritin
Red cell indices
CBC and RBC indicesCBC and RBC indices
80-96 fl.27-33 pg.33-36 g/dl
12.0-13.6%
Iron study, ferritinIron study, ferritin
TSAT < 20 %
Ferritin < 100 ng/ml
Iron deficiency anemia
Treatment of renal anemia
Benefit of anemia control in ESRDBenefit of anemia control in ESRD
Increased survival
Decreased cardiac complication
Improved quality of life
Increased exercise capacity
Decreased hospitalization
Target for anemia treatmentTarget for anemia treatment
Hb > 11 g/dl Hct > 33 %
Within 4 months
Ferritin 200-500 ng/ml
TSAT 30-40 %
Treatment of renal anemiaTreatment of renal anemia
Eryhtropoietin
Adequate dialysis Nutritional support
Iron therapy
Iron therapyIron therapy
Improved response to EPO
Reduced dose of EPO
Iron therapyIron therapy
VSVS
Oral iron IV iron
Iron sucrose(venofer)
Iron therapyIron therapy
- Ferrous sulfate 1 x 3
- Iron sucrose 25-150 mg/wk
Monitor:- serum ferritin, TSAT q 1-3 months
Iron therapy in CKDIron therapy in CKDSerum ferritin
Transferrin saturation
< 100 ng/ml - iron deficiency
> 800 ng/ml - stop iron Rx
< 20 % - iron deficiency
> 50 % - stop iron Rx
Side effects of iron therapySide effects of iron therapy
Oral iron - GI irritation- Diarrhea- Constipation
IV iron - anaphylactoid- hypotension- muscle cramp
Erythropoietin Erythropoietin
Erythropoietin α
Erythropoietin β Recormon
EprexEporonEpokrine
Erythropoietin Erythropoietin
80-120 U/kg/wk SC
120-180 U/kg/wk IV
Hb 1-2 g/dl/month
Erythropoietin Erythropoietin
Side effects
- hypertension
- PRCA
- headache
- Thrombosis
Inadequate erythropoietin responseInadequate erythropoietin response
Patient fail to attain the target Hb while
receiving:-
EPO 300 U/kg/wk SC
EPO 450 U/kg/wk IV4-6 months
Inadequate erythropoietin responseInadequate erythropoietin response
Iron deficiency anemia
Chronic blood loss
Chronic inflammation
Inadequate dialysis
hyperparathyroidism
top related